載入...
Etoposide damages female germ cells in the developing ovary
BACKGROUND: As with many anti-cancer drugs, the topoisomerase II inhibitor etoposide is considered safe for administration to women in the second and third trimesters of pregnancy, but assessment of effects on the developing fetus have been limited. The purpose of this research was to examine the ef...
Na minha lista:
| 發表在: | BMC Cancer |
|---|---|
| Main Authors: | , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
BioMed Central
2016
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4980800/ https://ncbi.nlm.nih.gov/pubmed/27510889 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-016-2505-9 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|